Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 9Phase 1/2 5Phase 1 4Phase EARLY_PHASE1 2Phase 3 2

Status

Terminated 4Completed 4Withdrawn 1Suspended 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Solid Tumor, Adult 1Rectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Completed × Positron-Emission Tomography × Clear all
NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Washington University School of Medicine

Phase 1 Completed
19 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT02297386 2018-08-06

[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
3 enrolled
Genitourinary

Prostatic Neoplasms

NCT01207895 2017-02-23

Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer

Vanderbilt-Ingram Cancer Center

Phase 1 Completed
5 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02437539 2015-08-24

uPAR-PET

Rigshospitalet, Denmark

Phase 1 Completed
10 enrolled
BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡